Recent studies show that, compared with normal tissue, Krm2 is up-regulated in several kinds of tumor including breast invasive carcinoma, colon adenocarcinoma, stomach adenocarcinoma (5). This evidence concerns the gene KREMEN2 and invasive breast carcinoma.